LBX Pharmacy Chain Joint Stock Company (SHA:603883)
China · Delayed Price · Currency is CNY 14.96
+0.05 (0.34%)
At close: Feb 27, 2026
SHA:603883 Cash Flow Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|
Period Ending | Sep '25 Sep 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 |
Net Income | 417.56 | 519.06 | 929.02 | 784.96 | 669.24 | 621.09 |
Depreciation & Amortization | 1,414 | 1,414 | 1,334 | 1,195 | 1,100 | 112.02 |
Other Amortization | 243.26 | 243.26 | 133.58 | 132.6 | 116.15 | 136.85 |
Loss (Gain) From Sale of Assets | 4.53 | 4.53 | -5.51 | -1.44 | -4.66 | 1.43 |
Asset Writedown & Restructuring Costs | 107.54 | 107.54 | - | - | - | - |
Loss (Gain) From Sale of Investments | -2.73 | -2.73 | -64.66 | -27.23 | -33.94 | -8.29 |
Provision & Write-off of Bad Debts | 1.09 | 1.09 | 10.59 | 7.18 | 5.65 | 10.05 |
Other Operating Activities | 1,357 | 354.58 | 405.87 | 427.38 | 313.98 | 214.69 |
Change in Accounts Receivable | -633.16 | -633.16 | 39.97 | -804.55 | -365.08 | -302.16 |
Change in Inventory | 576.06 | 576.06 | -202.63 | -974.55 | -226.86 | -354.55 |
Change in Accounts Payable | -526.47 | -526.47 | 150.8 | 1,562 | 721.6 | 1,034 |
Operating Cash Flow | 2,928 | 2,026 | 2,730 | 2,314 | 2,298 | 1,447 |
Operating Cash Flow Growth | 14.52% | -25.77% | 17.95% | 0.70% | 58.78% | 40.19% |
Capital Expenditures | -401.43 | -507.5 | -620.87 | -308.44 | -478.61 | -394.27 |
Sale of Property, Plant & Equipment | 16.68 | 8.24 | 7.48 | 11.58 | 19.53 | 3.95 |
Cash Acquisitions | -4.45 | -134.83 | -529.42 | -1,505 | -1,332 | -511.2 |
Divestitures | 12.16 | 25.94 | 14.12 | 8.86 | 60.04 | - |
Investment in Securities | 0.45 | -19.72 | 359.88 | 35.95 | -272.34 | -117.22 |
Other Investing Activities | 5.21 | - | 7.54 | 300.62 | 1.06 | 8.4 |
Investing Cash Flow | -371.38 | -627.88 | -761.26 | -1,457 | -2,002 | -1,010 |
Long-Term Debt Issued | - | 3,361 | 1,496 | 1,839 | 3,632 | 1,734 |
Total Debt Issued | 2,737 | 3,361 | 1,496 | 1,839 | 3,632 | 1,734 |
Short-Term Debt Repaid | - | - | - | -11.81 | -1.73 | -32.05 |
Long-Term Debt Repaid | - | -3,728 | -2,984 | -3,119 | -3,418 | -1,997 |
Total Debt Repaid | -4,296 | -3,728 | -2,984 | -3,131 | -3,420 | -2,029 |
Net Debt Issued (Repaid) | -1,559 | -367.49 | -1,488 | -1,292 | 211.88 | -295.03 |
Issuance of Common Stock | - | - | 6.3 | 1,774 | - | - |
Repurchase of Common Stock | -3.86 | -3.86 | -5.98 | -14.59 | -1.27 | -4.36 |
Common Dividends Paid | -363.4 | -714 | -374.71 | -302.16 | -168.23 | -176.96 |
Other Financing Activities | -465.82 | -262.99 | -565.93 | -307.88 | -455.59 | -18.85 |
Financing Cash Flow | -2,392 | -1,348 | -2,428 | -142.62 | -413.21 | -495.2 |
Foreign Exchange Rate Adjustments | 1.04 | - | -0.55 | 1.7 | -0.66 | - |
Net Cash Flow | 165.08 | 50.23 | -459.8 | 716.74 | -117.72 | -58.06 |
Free Cash Flow | 2,526 | 1,519 | 2,109 | 2,006 | 1,820 | 1,053 |
Free Cash Flow Growth | 36.21% | -27.98% | 5.14% | 10.23% | 72.78% | 73.76% |
Free Cash Flow Margin | 11.38% | 6.79% | 9.40% | 9.94% | 11.59% | 7.54% |
Free Cash Flow Per Share | 3.32 | 1.99 | 2.79 | 2.67 | 2.57 | 1.52 |
Cash Income Tax Paid | 911.68 | 976.07 | 911.78 | 655.76 | 542.13 | 568.3 |
Levered Free Cash Flow | 2,095 | 1,416 | 1,663 | 2,207 | 1,671 | 829.11 |
Unlevered Free Cash Flow | 2,182 | 1,527 | 1,779 | 2,352 | 1,791 | 865.67 |
Change in Working Capital | -615.3 | -615.3 | -12.8 | -203.9 | 132.28 | 359.63 |
Updated Sep 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.